Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

NUCLEIC ACID SEQUENCING REAGENT - ANVISA Registration 80839210002

Access comprehensive regulatory information for NUCLEIC ACID SEQUENCING REAGENT in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80839210002 and manufactured by ILLUMINA, INC.. The registration is held by ILLUMINA BRASIL PRODUTOS DE BIOTECNOLOGIA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including HIMEDIA LABORATORIES PVT.LTD., ILLUMINA, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
3 Competitors
5 Recent Registrations
80839210002
Registration Details
ANVISA Registration Number: 80839210002
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Registration Details

80839210002

25351319974202491

13147449000129

Company Information

ILLUMINA, INC.
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jul 08, 2024

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "NUCLEIC ACID SEQUENCING REAGENT"